Dec 30, 2025 • openPR.com
SOMEWHAT-BULLISH
Dementia Drugs Market 2025 Outlook: In-Depth Insights,
The global Dementia Drugs Market is projected to grow from US$26.14 Billion in 2025 to US$41.45 Billion by 2032, exhibiting a CAGR of 6.8%. This growth is driven by increasing industry demand and technological advancements, as highlighted in a new report by Coherent Market Insights. The report provides detailed insights into market dynamics, competitive landscapes, regional analysis, and identifies key companies and growth opportunities within the sector.
Dec 29, 2025 • FOX40 News
BEARISH
Securities Class Action Lawsuit Filed Against Viatris Inc. (VTRS) - Levi & Korsinsky Represents Shareholders
A class action securities lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) by Levi & Korsinsky, LLP, on behalf of shareholders who suffered losses due to alleged securities fraud between August 8, 2024, and February 26, 2025. The lawsuit claims that Viatris misrepresented the impact of a warning letter from the FDA regarding its Indore, India facility, leading to a significant stock price decline after the company released disappointing financial results and guidance for 2025. Shareholders are encouraged to learn about their rights to seek recovery.
Dec 28, 2025 • WJHL
BEARISH
Investor Alert: Deadline Approaching to Join Viatris Inc. (VTRS) Class Action - Contact Levi & Korsinsky
Levi & Korsinsky, LLP has announced a class action securities lawsuit against Viatris Inc. (NASDAQ:VTRS) for shareholders who suffered losses due to alleged securities fraud between August 8, 2024, and February 26, 2025. The lawsuit claims Viatris misrepresented the impact of an FDA warning letter on its Indore, India facility, leading to a significant stock price drop following disappointing 2025 financial guidance. Investors are encouraged to contact the firm to learn about their rights to recovery without cost or obligation.
Dec 26, 2025 • WJBF
NEUTRAL
Securities Class Action Lawsuit Filed Against Viatris Inc. (VTRS) - Levi & Korsinsky Represents Shareholders
A securities class action lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS), alleging that the company misled investors regarding the impact of a warning letter from the FDA concerning its Indore, India facility. Shareholders who suffered losses due to Viatris's stock decline on February 27, 2025, following disappointing financial results and revised guidance attributed to the FDA warning, are encouraged to contact Levi & Korsinsky for potential recovery. The firm represents shareholders and seeks to recover losses from alleged securities fraud between August 8, 2024, and February 26, 2025.
Dec 25, 2025 • 富途牛牛
BULLISH
Viatris Inc. Stock Climbs 1.8%, Outperforms Market
Viatris Inc. (VTRS) saw its stock climb 1.83%, outperforming the overall market. Concurrently, Unity Software (U.US) reported robust fourth-quarter financial results, with revenue increasing 35% year-over-year to $609 million, significantly exceeding analyst estimates. However, Unity still posted a quarterly loss of 66 cents per share.
Dec 24, 2025 • MSN
NEUTRAL
Viatris Inc. stock rises Wednesday, outperforms market
Viatris Inc. (VTRS) stock saw a gain of 2.15% on Wednesday, closing at $11.85, which outperformed the broader market's daily decline. Despite this daily gain, the stock remains below both its 52-week high and its 50-day moving average.